{"id":650523,"date":"2025-01-23T11:50:18","date_gmt":"2025-01-23T08:50:18","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/genomics-pioneer-steps-closer-to-dementia-treatment-breakthrough\/"},"modified":"2025-01-23T11:50:18","modified_gmt":"2025-01-23T08:50:18","slug":"genomics-pioneer-steps-closer-to-dementia-treatment-breakthrough","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/genomics-pioneer-steps-closer-to-dementia-treatment-breakthrough\/","title":{"rendered":"#Genomics pioneer steps closer to dementia treatment breakthrough"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_90 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6aff5f53cb085\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #dd3333;color:#dd3333\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #dd3333;color:#dd3333\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6aff5f53cb085\" checked aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/buradabiliyorum.com\/en\/genomics-pioneer-steps-closer-to-dementia-treatment-breakthrough\/#Changing_the_trajectory_of_dementia\" >Changing the trajectory of dementia<\/a><\/li><\/ul><\/nav><\/div>\n<div id=\"article-main-content\">\n<p><span style=\"font-weight: 400;\">An Icelandic scaleup has sparked hopes of a breakthrough in dementia treatment after raising \u20ac26.5mn for groundbreaking research.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Arctic Therapeutics (ATx) attracted the investment after pioneering a new <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/download-scripts-themes-apps\/\" data-internallinksmanager029f6b8e52c=\"9\" title=\"Download Scripts &amp; Themes &amp; Apps\" target=\"_blank\" rel=\"noopener\">app<\/a>roach to drug development. Founded in 2015, the company first analyses genomic data with bioinformatics \u2014 a blend of computer <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/sciencee\/\" data-internallinksmanager029f6b8e52c=\"5\" title=\"Science\" target=\"_blank\" rel=\"noopener\">science<\/a> and biology.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">After identifying disease-associated genes and proteins, ATx targets the root causes of a given condition.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to the scaleup, the process cuts the risks, costs, and time involved in developing treatments.<\/span><\/p>\n<div class=\"inarticle-wrapper latest channel-cta hs-embed-tnw\">\n<div id=\"hs-embed-tnw\" class=\"channel-cta-wrapper\">\n<div class=\"channel-cta-img\"><img decoding=\"async\" class=\"js-lazy\" src=\"https:\/\/s3.eu-west-1.amazonaws.com\/tnw.events\/hardfork-2018\/uploads\/visuals\/tnw-newsletter.png\"\/><\/div>\n<p><img decoding=\"async\" src=\"https:\/\/s3.eu-west-1.amazonaws.com\/tnw.events\/hardfork-2018\/uploads\/visuals\/tnw-newsletter.png\"\/><\/p>\n<div class=\"channel-cta-input\">\n<p class=\"channel-cta-title\">The \ud83d\udc9c of EU tech<\/p>\n<p class=\"channel-cta-tagline\">The latest rumblings from the EU tech scene, a story from our wise ol&#8217; founder Boris, and some questionable AI art. It&#8217;s free, every week, in your inbox. Sign up now!<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p><span style=\"font-weight: 400;\">The new financing could push the benefits closer towards patients. ATx said the <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/watch-movies-tv-seriess\/\" data-internallinksmanager029f6b8e52c=\"8\" title=\"Watch Movies &amp; TV Series\" target=\"_blank\" rel=\"noopener\">Series<\/a> A funds will advance two frontrunner drugs: AT-001 and AT-004.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">AT-001 has proven particularly promising. The treatment focuses on dementia caused by harmful accumulations of protein. Its primary target is amyloid-induced angiopathy, a condition characterised by proteins amassing in the walls of the brain\u2019s arteries.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Taken orally, AT-001 disrupts and dissolves these harmful protein clusters. Consequently, the treatment could reduce the risks of dementia.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">ATx is confident of stalling the condition\u2019s progression. The company also believes the drug could delay dementia\u2019s onset \u2014 and even reverse its course.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00cdvar H\u00e1konarson, the CEO and co-founder of ATx, said the treatment has \u201ctransformative potential.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cAT-001 offers hope for earlier intervention and even preventive use in individuals at high risk of developing dementia based on our biomarker signals,\u201d he told TNW.<\/span><\/p>\n<figure class=\"post-image post-mediaBleed aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-1411918 js-lazy\" alt=\"Arctic Therapies co-founder and CEO \u00cdvar H\u00e1konarson\" width=\"1640\" height=\"1093\" src=\"https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2025\/01\/AT-Ivar-Hakonarso.jpg\"\/><figcaption>Credit: ATx<\/figcaption><figcaption>H\u00e1konarson co-founded ATx\u00a0in 2015 as a spin-off from the US-based Center for Applied Genomics (CAG). Credit: ATx<\/figcaption><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-1411918\" src=\"https:\/\/cdn0.tnwcdn.com\/wp-content\/blogs.dir\/1\/files\/2025\/01\/AT-Ivar-Hakonarso.jpg\" alt=\"Arctic Therapies co-founder and CEO \u00cdvar H\u00e1konarson\" width=\"1640\" height=\"1093\" srcset=\"\"\/><\/figure>\n<h2><span class=\"ez-toc-section\" id=\"Changing_the_trajectory_of_dementia\"><\/span>Changing the trajectory of dementia<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Tests on AT-001 are progressing rapidly. Last year, the European Medicines Agency (EMA) approved a new clinical trial that will probe the drug\u2019s effects on HCCAA \u2014 a rare form of familial dementia.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">ATx also plans to launch a clinical trial for AT-004. The study aims to show the treatment is effective and safe for acne, before expanding into other inflammatory skin diseases.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">ATx expects the new funds to accelerate the research.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A syndicate of international investors participated in the round. Among them is the European Commission\u2019s EIC Fund, which supports companies developing disruptive tech.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Svetoslava Georgieva, the chair of the EIC Fund Board, described the ATx financing as both an opportunity and a responsibility.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cIn Europe alone, dementia affects over 10 million people \u2014 placing immense strain on families, healthcare systems, and economies,\u201d she said in a statement.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cBy providing an equity investment in Arctic Therapeutics, the EIC Fund is supporting groundbreaking preventive treatments that have the potential to change the trajectory of this crisis, improve quality of life, and alleviate the burden on healthcare infrastructure worldwide.\u201d<\/span><\/p>\n<\/p><\/div>\n<blockquote><p><strong><span style=\"color: #ff6600;\">If you liked the article, do not forget to share it with your friends. Follow us on\u00a0<span style=\"color: #ff0000;\"><a style=\"color: #ff0000;\" href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN63nwsw68G3Aw\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\"><strong>If you want to read more like this article, you can visit our <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/en.buradabiliyorum.com\/category\/technology\/\" target=\"_blank\" >Technology category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<p><span style=\"color: black;\"><a style=\"color: #ff9900;\" href=\"https:\/\/thenextweb.com\/news\/atx-raises-funds-for-dementia-alzheimers-treatment\" target=\"_blank\" >Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>An Icelandic scaleup has sparked hopes of a breakthrough in dementia treatment after raising \u20ac26.5mn for groundbreaking research. Arctic Therapeutics (ATx) attracted the investment after pioneering a new approach to drug development. Founded in 2015, the company first analyses genomic data with bioinformatics \u2014 a blend of computer science and biology. After identifying disease-associated genes&#8230;<\/p>\n","protected":false},"author":1,"featured_media":650524,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/img-cdn.tnwcdn.com\/image\/tnw-blurple?filter_last=1&fit=1280%2C640&url=https%3A%2F%2Fcdn0.tnwcdn.com%2Fwp-content%2Fblogs.dir%2F1%2Ffiles%2F2025%2F01%2FUntitled-design-8.jpg&signature=2415bf96264a463f0045a37587ad904f","fifu_image_alt":"","footnotes":""},"categories":[18],"tags":[],"class_list":["post-650523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/650523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=650523"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/650523\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/650524"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=650523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=650523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=650523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}